First Manhattan CO Acer Therapeutics Inc. Transaction History

First Manhattan CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$1.95 - $3.93 $5,850 - $11,790	-3,000 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$3.45 - $26.86 $34,500 - $268,600	-10,000 Reduced 76.92%	3,000 $11,000
Q4 2018 Jan 30, 2019	BUY	$16.55 - $30.22 $66,200 - $120,880	4,000 Added 44.44%	13,000 $261,000
Q3 2018 Oct 15, 2018	BUY	$18.0 - $32.83 $72,000 - $131,320	4,000 Added 80.0%	9,000 $277,000
Q4 2017 Jan 22, 2018	BUY	$11.81 - $19.35 $59,050 - $96,750	5,000	5,000 $69,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.